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Abstract
Background and Objective Psychotropic drug use is high in nursing homes in Belgium. A practice improvement initiative 
(including education, professional support and the transition towards person-centred care) achieved significant reductions in 
psychotropic drug use. The initiative outline was transcribed into a general intervention template, and consequently imple-
mented in five nursing homes (in mixed locations and with a mixed character) in preparation for a future broader roll-out in 
Belgium. The impact of the intervention on the use of psychotropic drugs in these five nursing homes is reported in this paper.
Methods The general intervention template was fitted into the individual nursing home setting. Education for the nursing 
home personnel on psychotropic drugs and non-pharmacological alternatives, as well as details for a transition to person-
centred care was provided. Psychotropic drug use was recorded using a dynamic cohort study design with cross-sectional 
observations (November 2016–November 2017).
Results At baseline, participants’ (n = 677) mean age was 85.6 years (range 54–109 years), with 72.6% female. Mean medica-
tion intake was 8.5 (range 1–22), predominantly central nervous system drugs (Anatomic Therapeutic Chemical classification 
N, 88.8%). Long-term (> 3 months) psychotropic drug use (62.0%) and concomitant psychotropic drug use (31.5% taking 
two or more medications) were high. After 12 months, the prevalence of long-term psychotropic drug use decreased signifi-
cantly (from 62.0 to 52.9%, p < 0.001), likewise the combined use of psychotropic drugs (from 31.5 to 24.0%, p = 0.001). 
The decrease in the prevalence of antidepressant and hypnosedative use was significant (respectively, from 32.2 to 23.4%, 
p < 0.001, and from 35.3 to 28.7%, p = 0.006) in contrast to antipsychotic use (from 17.1 to 15.9%, p = 0.522).
Conclusions The stand-alone adaptation of the previously reported initiative using a general template was possible. This 
intervention resulted in a significant decrease in psychotropic drug use (predominantly hypnosedatives and antidepressants) 
among nursing home residents after 12 months.
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1 Introduction
Nursing home residents are amongst those with the high-
est level of multimorbidity, care dependency and the high-
est medication intake [1]. A high medication intake often 
includes high use of psychotropic medications (e.g. hypno-
sedatives, antidepressants and antipsychotics) [2]. These are 
often prescribed because of the higher prevalence of sleep-
ing problems and/or mental disorders, in particular dementia 
and related behavioural and psychological symptoms [3–5].
Psychotropic medications are indicated in a limited num-
ber of cases, i.e. only when a non-pharmacological approach 
seems insufficient, and only as a well-tailored, monitored 
and time-limited therapy [6]. The reality is that these drugs 
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Key Points 
The use of psychotropic medications (hypnosedatives, 
antidepressants and antipsychotics) remains high among 
nursing home residents in Belgium, despite diverse cam-
paigns to reduce use.
An earlier initiative proved successful in reducing the 
use of psychotropic drugs. The main elements in this 
initiative are education, professional support for nursing 
home residents, involving every member of the nurs-
ing home personnel, and predominantly the transition 
towards person-centred care. The previous intervention 
was recorded on a template, and tested for implementa-
tion in five nursing homes.
The implementation of the intervention, and the adapta-
tion to an individual nursing home setting was possible. 
Overall, the intervention proved again to successfully 
reduce the prevalence of psychotropic drug use, pre-
dominantly for hypnosedatives and antidepressants, but 
not for antipsychotics.
are often prescribed, often mutually combined and often on 
a long-term basis without reassessment of the appropriate-
ness [7, 8]. Specific for the nursing home setting, the quality 
of psychotropic drug prescribing is influenced by extreme 
frailty and care dependency of the residents, a limited physi-
cian’s presence on the floor, nurses’ influence on the choice 
of pharmacotherapy, and limited staff and knowledge of 
geriatric pharmacotherapy [9].
The prevalence of psychotropic drug use is high in 
Belgium, and especially high in Belgian nursing homes 
[2, 10–12]. Recently, a practice improvement initiative 
(“Towards an effective and efficient use of psychotropic 
drugs”, the Leiehome project) was initiated in a nursing 
home in Flanders, Belgium aiming to reduce high in-house 
psychotropic drug use [13]. The initiative started with edu-
cational sessions related to respective psychotropic drug 
classes (i.e. hypnosedatives, antipsychotics and antidepres-
sants), which were offered to the complete nursing home 
staff (including nurses, physiotherapists, occupational thera-
pists and logistic personnel). Subsequently, the focus was put 
on the transition to patient-centred care through professional 
support including offering a variety of meaningful activi-
ties to the nursing home residents [14]. For every current 
prescribed psychotropic drug, the original indication for the 
prescription was reassessed, as well as exploration of cur-
rent options for a discontinuation. For every potential new 
prescription for a psychotropic drug, the indication was cau-
tiously assessed, and the possibility of adding an end date for 
the treatment was always discussed [13].This resulted in an 
overall reduction in psychotropic drug use from 72 to 62%, 
in hypnosedative use by 20% and antidepressant use by 17% 
over the period of 12 months.
The positive effect of this nursing home initiative led to 
funding from the Flemish Government for an implementa-
tion study with the aim to amend the original intervention to 
a template for a future roll-out. The aim of this study was to 
investigate whether the intervention, starting from a general 
intervention template, could be successfully implemented in 
separate nursing homes, resulting in a decreased prevalence 
of psychotropic drug users (hypnosedatives, antidepressants 
and antipsychotics).
2  Methods
This implementation study was tested in five nursing homes 
with a mixed character (private to public) over a follow-up 
period of 12 months.
2.1  Design
For this study, the outlines from the earlier practice improve-
ment initiative “Towards an effective and efficient use of 
psychotropic drugs” in a nursing home in Flanders, Belgium 
were used [13]. This initiative has resulted in a significant 
reduction in the prevalence of long-term psychotropic drug 
users (predominantly hypnosedatives and antidepressants) 
[13]. As a result of the significant reductions and positive 
experiences during this initiative, it was decided to perform 
an implementation study for a potential future roll-out.
An implementation study was performed using a 
dynamic, prospective cohort study design, with an obser-
vation period over the course of 12 months. The dynamic 
cohort implies that this study is examining the psychotropic 
medication intake of the nursing home population as cross-
sectional observations. As the initial initiative demonstrated 
significant improvement, no control group was assigned in 
this study.
2.2  Eligibility Criteria
The study was conducted in five nursing homes, which 
reflect the diversity in character (public or private setting), 
and region (urban, rural) of nursing homes in Flanders. To 
be eligible, the nursing homes needed the following: (1) at 
least two-thirds of all general practitioners (GPs) agreeing to 
participate; (2) assignment of an internal project leader (0.2 
full-time equivalent [FTE]); and (3) an electronic system for 
the organisation of the medication charts.
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2.3  Intervention
The protocol of the earlier practice improvement initiative was 
used, to set the outlines of intervention into a general interven-
tion template [13]. From now on, the wording intervention to 
describe the translation of the earlier initiative is maintained.
The template was printed out and given to the nursing 
homes, but was also reviewable online. It provided extensive 
information on what to perform, for whom, at what stage, 
and using what materials. It provided supporting material 
and instructions for each phase in the intervention (e.g. back-
ground information on the educational sessions, delineation 
of non-pharmacological alternatives). Furthermore, all avail-
able documents from the first study (e.g. brochures, flyers) 
were distributed and stored online.
The participating nursing homes could adapt these instruc-
tions to best fit their own nursing home setting, to achieve an 
optimal implementation of the intervention. This was super-
vised by an internal project leader (0.2 FTE). During the prep-
aration and information phase, a collaborator from the first 
practice improvement initiative [13] could be contacted for 
additional information and support by all the nursing homes.
A preparation and information phase (August 2016–Octo-
ber 2016) preceded the intervention period to inform the 
nursing home director, coordinating physician, treating GPs 
and pharmacist on the next steps, and to assign team leaders 
responsible for the implementation of the intervention. The 
realisation of the intervention (November 2016–November 
2017) consisted of a transition to person-centred care, sup-
ported by education, medication assessment and judicious 
deprescribing.
2.3.1  Aspects of the Intervention
Figure 1 provides the flow of the intervention. An overview 
of the intervention is given in Box 1.
The first aspect in the template was to hold educational 
sessions for GPs and the nursing personnel separately. Each 
session dealt with a particular topic (sleeping problems, 
depression in old age, challenging behaviour) related to the 
prescribing of a psychotropic drug. The content of the courses 
was focused on evidence-based practice, reductions in psy-
chotropic drug use (including specific guidance on how to 
deprescribe) and non-pharmacological alternatives. The edu-
cational sessions were held at different time periods so that 
most of the nursing home personnel could attend. The edu-
cational sessions were recorded and made available online.
The thorough medication assessment for all residents by 
the GP, driven by the nurse was the next step of the interven-
tion. For all psychotropic drugs (long term and as needed), 
the nurse investigated the duration of the therapy; the origi-
nal indication for treatment was assessed and reviewed 
whether it was still present. Afterwards, the GP was con-
tacted by the nurse to review the psychotropic medication. 
In agreement with the nursing home resident and/or their 
relatives, it was reviewed whether discontinuation was pos-
sible or whether the dose or duration could be lowered. The 
main aspect during the whole intervention was the transition 
towards person-centred care. The individual’s needs, history 
and values as well as the desired health outcome of a patient 
were heard and the care was tailored accordingly.
The transition towards person-centred care was considered 
key in the execution of the intervention. It was facilitated by 
Fig. 1  Flow and phases of the 
intervention
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an awareness campaign for all personnel (healthcare profes-
sionals, logistics, cleaning staff) and all nursing home resi-
dents. Brochures were given to the patients and their relatives, 
and flyers were displayed throughout the nursing homes.
Nurses had a leading role in the intervention, owing to 
their data collection, daily contacts with residents and their 
contacts with GPs to motivate them for the intervention. 
However, for all personnel, multidisciplinary meetings were 
encouraged to ensure a positive working attitude.
Together with the potential deprescribing of psychotropic 
drugs, it was reviewed how non-pharmacological alterna-
tives could aid the deprescribing process for each individual 
resident (for instance, music or aroma therapy). Instead of 
psychotropic drugs, other alternatives (including meaning-
ful activities) were tailored to the resident (e.g. offering a 
warm glass of milk in the evening instead of a hypnoseda-
tive, or placing a ribbon in an open doorway to halt wander-
ing behaviour to other rooms) [14].
Box 1. Overview of the intervention
Educational courses
Topic Explanation
Sleeping 
problems
Physiological changes in the sleeping pattern of older 
adults
Causes of insomnia and causal interventions
Risks and benefits of hypnosedatives
Non-pharmacological interventions: effectiveness, 
practical application
Old age 
depression
Detecting depression and depressive symptoms
Interventions (basic, psychotherapy, handling 
rebound depression)
Risks and benefits of antidepressants
Non-pharmacological interventions: effectiveness, 
practical application
Challenging 
behaviour
Differentiating BPSD and other challenging 
 behaviour
Prevention, watchful waiting or specific 
 interventions?
Risks and benefits of anti-psychotics
Non-pharmacological interventions: effectiveness, 
practical application
Transition to person-centred care
Actions Questions/tasks
Assessment of psychotropic drug 
intake by nurses
How many? Which?
Assessment of indications for pre-
scribing psychotropic drugs
Is the indication still present?
Beliefs and wishes of patient and 
family regarding psychotropic 
drugs
On what ground did the patient 
want a pharmacological treat-
ment? Is discontinuation an 
option?
Transition to person-centred care
Evaluation of psychotropic drug 
intake
Was it effective? Did it affect 
the resident negatively 
(worsening BPSD, depressive 
behaviour …?)
Was there a dose reduction in 
the past? Was it effective?
Involvement of the patient and his/
her family
Education, explaining risks 
and benefits, understanding 
beliefs of residents
Observation and reporting of 
behavioural changes, and linking 
back to medication intake
How do the residents cope with 
discontinuation of psycho-
tropic drugs?
Frequent observation of non-
verbal signals in the case of 
patients with dementia
Report behaviour in an objec-
tive manner
Organise multidisciplinary meet-
ings
Describe changes in behaviour, 
hold reflection moments. 
Repeat the educational 
sessions. Search as a team 
for the most suitable non-
pharmacological approach 
for one resident. Interact with 
volunteers
BPSD behavioural and psychological symptoms of dementia
2.4  Data Collection and Data Processing
Data were collected for all residents from their medical 
records and electronic medication administration charts at 
fixed time points in the observation period. Data included 
personal characteristics (date of birth, sex) and medication 
data.
Functional characteristics included cognitive status 
(scored by the Mini-Mental State Examination, range 0–30 
with 0 indicating severe cognitive impairment), activities 
of daily living (scored by Katz Activities of Daily Living, 
Activities of Daily Living scale, range 6–24 with 6 indicat-
ing complete care independent), and disorientation in time 
and place (scored by the Katz score, range 0–8 with 8 cor-
responding with complete disorientation in time and place). 
The use of the Katz disorientation scale is mandatory in 
nursing homes in Belgium and is easy for nurses and nurs-
ing assistants to complete. It is an index applied by means 
of an interview and observation, equally valid in assessing 
disorientation in time and place in patients with and with-
out dementia. High-care dependency was defined as a score 
above 17 on the Katz Activities of Daily Living, dementia 
symptoms were defined as scores above 5 on the Katz diso-
rientation scale.
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Medication data included all prescribed medications, 
long term, short term or as needed. The medications were 
coded according to the Anatomical Therapeutic Chemical 
(ATC) classification (World Health Organization ATC/DDD 
2013) using a data program based on the official register of 
medications available on the Belgian market. Focus was on 
psychotropic medications (ATC pharmacological subgroups 
N05A, N06A and N05BA-N05CD-N05CF, i.e. antipsychot-
ics, antidepressants and hypnosedatives, respectively). Poly-
pharmacy was defined as the long-term use of five or more 
medications. Long-term use was defined as use longer than 
3 months (i.e. 90 daily defined doses). Combination therapy 
was defined as the use of two or more psychotropic drugs, or 
a combined use within therapeutic subgroups.
2.5  Statistical Analysis
We encountered no missing data. Administrative data were 
collected from the nursing home systems, and medication 
data could be retrieved from the medication administration 
chart at any time.
SPSS 23.0 (Statistical Package for Social Sciences; SPSS 
Inc., Chicago, IL, USA) was used for statistical analysis. 
For the descriptive statistics, means, medians or propor-
tions were used. We performed a comparison of continu-
ous data using t tests or non-parametric tests (Wilcoxon and 
Kruskal–Wallis tests) in the case of skewed data. Analysis of 
categorical variables was performed using Chi squared tests.
The main endpoint was the prevalence of psychotropic 
drug users. For this study, only the baseline and final time 
point were compared within this dynamic cohort. The 
paired analysis was performed in a closed cohort, including 
the residents present at both baseline and at the end of the 
study. All drug use at baseline and at the end of the study for 
each patient was paired and compared with paired analysis 
techniques.
2.6  Ethics Approval
The original intervention received funding from the Fund 
for Addictions (Fonds voor Verslavingen in Dutch) from the 
Federal Public Service for Health, Food Chain Safety, and 
Environment. Given the positive results, a new proposal was 
submitted. Funding was received from the Flemish Agency 
for Care and Health (Vlaams Agentschap voor Zorg en 
Gezondheid in Dutch) with the aim to test the potential roll-
out of the intervention across nursing homes.
An approval was granted by the Biomedical Ethics Com-
mittee of Gent University Hospital (B670201420698). Per-
mission was given by the board of directors and the super-
vising physician of each participating nursing home. All data 
were codified and anonymised.
3  Results
3.1  Description of the Nursing Homes and their 
Residents
There were three private and two public nursing homes (des-
ignated NH 1–5), two were located in a rural region, one in 
a suburban region and two in an urban region. The number 
of beds ranged between 104 and 177. The number of nurses 
and nursing assistants (expressed in FTE) ranged between 
11.0 and 14.9.
In total, 677 residents participated across the five partici-
pating nursing homes. Their mean age was 85.6 years (range 
54–109 years), with 72.6% female. The populations in the 
different nursing homes varied; the level of complete care 
dependency and/or disorientation ranged between 37.4% 
(NH 4) and 61.6% (NH 1). For a full background and over-
view of the nursing homes and the residents’ characteristics, 
see Table 1.
3.2  Description of the Drug Use at Baseline
The mean number of drugs per patient used at baseline was 
8.5 drugs (range 1–22), predominantly for long-term use 
(7.2, range 0–19). There was a mean number of ‘as-needed 
use’ of 1.1 (range 0–12). The mean number of drugs varied 
between 6.9 and 9.8 across nursing homes. For a full com-
parison on the mean total and mean long-term medication 
intake across the nursing homes, see Fig. 2.
At the main anatomical ATC level, nervous system drugs 
were predominantly consumed by the patients (89% of 
patients taking a nervous system drug, e.g. analgesics and 
psychotropic drugs), followed by alimentary drugs (e.g. vita-
mins, anti-diabetic medications) and cardiovascular medica-
tions (e.g. statins, beta-blockers). For a full overview of the 
drug use, and all main anatomical ATC classes, see Table 2.
The prevalence of long-term psychotropic drug users at 
baseline was 62.0%, with a mean psychotropic drug use of 
1.4 (range 0–7). Combined use of two or more psychotropic 
drugs was present in 31.5% of the population. The preva-
lence of long-term antidepressant users was 35.3% (range 
0–3), 32.2% (range 0–4) for long-term hypnosedative users 
and 17.1% (range 0–3) for long-term antipsychotic users.
3.3  Effect of the Intervention between Baseline 
and the End of the Study
There was a significant decrease in the mean number of 
medications used (from 8.5 to 7.2, Wilcoxon signed-rank 
test, p < 0.001) at the end of the follow-up period (after 
12 months). The mean number of long-term and as-needed 
medications dropped significantly (respectively from 7.2 to 
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6.2; p < 0.001 and from 1.1 to 0.9; p = 0.014). The preva-
lence of residents with polypharmacy (long-term intake of 
five or more medications) dropped significantly from 76.8% 
to 67.6% (p < 0.001).
In addition, there was a noticeable shift in the preva-
lence of older adults with concomitant use of long-term 
and as-needed psychotropic medications. The prevalence 
of older adults with multiple medications decreased sig-
nificantly (from 31.5% to 24.0%, p = 0.001), and the preva-
lence of older adults with no psychotropic drugs increased 
significantly. The prevalence of nursing home residents 
with no psychotropic drugs increased from 38.0% to 47.1% 
(p > 0.001). For a full overview of the concomitant use of 
psychotropic drugs, see Fig. 3.
At the end of the follow-up, the overall psychotropic drug 
user prevalence decreased significantly from 62.0 to 52.9% 
(p < 0.001). The effect was most noticeable in the preva-
lence of hypnosedatives and antidepressants. The prevalence 
of hypnosedative users dropped significantly from 32.2 to 
23.4% (p < 0.001) and the prevalence of antidepressant 
users dropped significantly from 35.3 to 28.7% (p = 0.006). 
There was no significant decrease in the prevalence of 
Table 1  General characteristics of the nursing homes (NHs) and NH residents at baseline (November 2016)
Bold values indicate the results of the total population of NH residents (n = 677)
ADL Activities of Daily Living (range 6–24, 24 meaning total care dependence), FTE full-time equivalent, MMSE Mini-Mental State Examina-
tion (range 0–30, 30 meaning cognitively able)
Nursing home characteristics NH 1 NH 2 NH 3 NH 4 NH 5
Character Private Private Private Public Public
Region Rural Rural Suburban Urban Urban
Capacity (number of beds) 104 120 141 177 174
Health personnel per 30 residents (in FTE) 14.9 13.6 13.2 14.1 11.0
Ratio nurses 3.8 3.9 3.8 5.1 5.4
Ratio nurse assistants 8.7 8.3 7.3 7.0 5.9
NH residents’ characteristics Total
Number of residents 677 99 121 133 160 164
Female sex (%) 72.6 74.7 76.0 78.0 69.6 72.6
Mean age (years) 85.6 85.0 85.6 87.5 85.2 84.5
Age range (years) 62–97 59–103 54–108 58–109 60–97
Mean MMSE 17.7 17.4 18.3 18.9 15.9 18.4
Dementia symptoms (%) 51.5 47.1 45.7 47.1 58.0 55.6
Mean Katz ADL 17.1 18.8 17.5 17.0 17.1 15.8
High-care dependency (ADL > 17, %) 52.6 68.6 56.0 50.7 53.4 42.0
Fig. 2  Boxplots showing the total number of medications (left) and number of long-term medications (right) per nursing home at baseline
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antipsychotic users (from 17.1 to 15.9%, p = 0.522). An 
overview of the evolution in prevalence of psychotropic drug 
users can be seen in Fig. 4.
Table 3 provides the results of the paired analyses per 
nursing home. The overall prevalence of psychotropic drug 
users decreased significantly in NH 1, NH 3 and NH 4. At 
the different subclasses, the prevalence of hypnosedative 
users decreased significantly only in NH 1. The prevalence 
of antidepressant users decreased significantly in NH 1 and 
NH 3.
Table 2  Overview of drug use and the main anatomical medication groups (first Anatomical Therapeutic Chemical [ATC] level) in the total at 
baseline (November 2016)
Main medication groups with a prevalence over 15% are shown
Bold values indicate the results of the total population of NH residents (n = 677)
NH nursing home
All NH 1 NH 2 NH 3 NH 4 NH 5
Residents’ mean drug use, % 8.5 9.7 10.6 9.1 6.8 7.6
 Long-term prescriptions 98.0 97.5 97.0 97.5 95.1
 As-needed prescriptions 50.5 78.5 72.2 8.8 53.7
 Short-term prescriptions 14.1 2.5 1.5 2.5 5.5
Main medication groups, % Total
 Nervous system ATC N 88.8 87.9 95.0 96.2 80.6 86.6
 Alimentary ATC A 87.3 94.9 95.0 88.7 80.0 82.9
 Cardiovascular ATC C 79.3 87.9 81.0 79.7 73.8 78.0
 Blood (forming) ATC B 63.2 71.7 63.6 61.7 59.4 62.8
 Respiratory ATC R 21.4 27.3 21.5 21.8 19.4 19.5
 Musculoskeletal ATC M 15.7 15.2 23.1 12.0 12.5 16.5
Fig. 3  Prevalence of concomi-
tant long-term psychotropic 
drug use at different times dur-
ing the follow-up
Author's personal copy
 M. Wauters et al.
4  Discussion
In this study, we described the implementation of an earlier 
successful practice improvement initiative in five nursing 
homes as preparation for a future broader roll-out [13]. The 
initiative was transcribed into a general intervention tem-
plate, denoting every aspect so that a participating nursing 
home could employ the template to best fit its own nursing 
home setting. Central in the intervention was the transition 
towards a more person-centred approach (how can we help 
an individual patient best to discontinue his/her psychotropic 
drugs?), supported by educational sessions and professional 
support. The intervention resulted in a significant decrease 
in psychotropic drug use.
Fig. 4  Evolution of the prevalence of psychotropic drug use across the time points
Table 3  Paired analysis of the prevalence of psychotropic drug users in the closed cohort of patients at baseline (T0) and after 1 year (T12 m) 
[n = 513]
Bold values indicate significant results
NH nursing home
Time NH 1 NH 2 NH 3 NH 4 NH 5
T0 T12 m P value T0 T12 m P value T0 T12 m P value T0 T12 m P value T0 T12 m P value
Psychotropic drug use 72.7 58.6 0.036 71.9 66.4 0.353 69.9 57.8 0.039 56.3 42.1 0.004 47.6 53.5 0.277
 Hypnosedative use 47.5 30.3 0.013 43.0 36.1 0.271 28.6 19.3 0.074 26.9 19.9 0.095 23.2 19.2 0.371
 Antidepressant use 47.5 36.4 0.043 37.2 43.4 0.341 47.4 28.1 0.001 28.8 20.7 0.056 23.2 28.5 0.266
 Antipsychotic use 21.2 19.2 0.470 16.5 11.5 0.265 21.8 20.7 0.831 13.1 14.0 0.793 15.2 17.4 0.586
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The main findings include an overall and significant 
decrease of 9.1% in the prevalence of long-term psycho-
tropic drug users over the period of 12 months. The preva-
lence of patients with combined use of psychotropic drugs 
decreased as well, the prevalence of nursing home residents 
with three or more psychotropic drugs dropped by 9.5%. The 
changes were most noticeable in the prevalence of hypnosed-
ative and antidepressant users with significant decreases by 
8.8% and 6.6%, respectively, over the period of 12 months.
4.1  Strengths and Limitations
This study provides evidence to add to the growing body of 
knowledge that suggests a multidisciplinary approach can 
lead to significant decreases in overall psychotropic drug 
use, predominantly in the prevalence of hypnosedative and 
antidepressant users. The gradual but continuous longitu-
dinal change in the positive attitudes of nursing home per-
sonnel was key for this intervention. The intervention had 
a sustained effect over the 1-year study period in a real-
istic and dynamic sample of nursing home residents. The 
transcription into a general intervention template ensured 
a higher transferability, yet we did not conduct a process 
evaluation for the implementation of the intervention, nor 
did we perform a qualitative exploration of the experience 
of nurses, personnel and nursing home residents.
The main limitations of this implementation study were 
the small number of nursing homes and the lack of a control 
group. In the present study, a dynamic cohort with repeated 
cross-sectional observations was used, taking into account 
newly admitted nursing home residents. The outlines of an 
earlier practice improvement initiative (which has demon-
strated significant results) were used, omitting the need for 
a control group. Yet, without a control group and without 
assessing other confounding variables, we are not able to 
determine if the discontinuation of psychotropic drugs was 
influenced by factors other than the intervention.
Another limitation was a potential ascertainment bias, 
meaning that the most eager nursing home might have vol-
unteered to participate. The main outcome of this study was 
the prevalence of psychotropic drug users. Other patient-
reported outcome measures (e.g. quality of life, mortality) 
were not assessed. The study team was also unable to assess 
dosage reductions in a standardised manner.
4.2  Relationships to Other Findings
4.2.1  Psychotropic Drug Use Remains High in Belgium
Our study confirmed the high drug use among nursing home 
residents in Flanders, Belgium [2], predominantly the high 
use of central nervous system, cardiovascular and alimen-
tary medications [15]. In comparison with findings from the 
Prescribing in Homes for the Elderly in BElgium (PHEBE, 
2006) study, the prevalence of psychotropic drug use has 
decreased [10]. The prevalence of psychotropic drug use is 
similar to other recent research in nursing homes in Belgium, 
albeit there was a higher hypnosedative and antidepressant 
use and a lower antipsychotic use in the present study [2].
4.2.2  As‑needed Psychotropic Drugs are Often Given Long 
Term
Psychotropic drugs are commonly prescribed, yet often 
without an appropriate indication [16, 17]. In the PROPER 
I-study, it is claimed that around 10% of all psychotropic 
drugs prescribed for nursing home residents with dementia 
are appropriate (in terms of indication and duration) [18]. 
However, it is only recently been highlighted that psycho-
tropic drugs are often underestimated in studies owing to 
the hidden nature of ‘as-needed’ medications [19]. Studies 
often focus solely on long-term medications, yet psycho-
tropic drugs can also be prescribed as needed only (or pro re 
nata) but actually given on a regular basis for a long period 
of time. In this study, a high prevalence of as-needed medi-
cation was noted at the start, but a decrease occurred. We 
carefully controlled changes in the medication prescriptions 
to review if a transition from long-term use to as needed took 
place, but no substitution to as-needed medications at the 
end of the observation period was observed.
4.2.3  Interventions Affect Hypnosedatives 
and Anti‑Depressants, but not Antipsychotics
Nurses and nursing assistants face a high workload in the 
care of nursing home residents. Neuropsychiatric symptoms 
common in residents with dementia pose serious challenges 
to the nursing home staff [20], potentially compromising 
effective care. Nursing home personnel might have concerns 
about relapsing or worsening symptoms, and the occurrence 
of withdrawal symptoms when deprescribing psychotropic 
drugs [21], but earlier findings suggest that a discontinuation 
of antipsychotics can be achieved in the majority of patients 
without major effects on dementia-related behavioural and 
psychological symptoms. Antipsychotics in patients with 
severe symptoms at baseline might however be more diffi-
cult to withdraw [22–24]. However, it must be remembered 
that the choice between antipsychotics or use of a physical 
restraint is not easy to make.
The evidence on reducing psychotropic drugs in nurs-
ing home residents through various interventions is still 
limited and not consistent [25]. In a French study, audits 
and interdisciplinary team meetings did not result in sig-
nificant changes in the prevalence of benzodiazepine users 
(n = 3973), potentially owing to external factors affecting 
the intervention [26].
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Both in the present and previous study, we observed that 
the discontinuation of antipsychotics was not successful. 
The RedUSe (Reducing Use of Sedatives) trial assessed 
the impact of a multi-strategic interdisciplinary interven-
tion on antipsychotic and benzodiazepine prescribing in 
Australian residential aged care facilities. The authors 
reported a reduction in the prevalence of antipsychotic 
and benzodiazepine users, and also in dose reductions 
[27–29]. The intervention in RedUSe consisted of an audit 
and feedback, staff education, an interdisciplinary review 
and a prominent role for a nurse [27]. The RedUSe trial 
reported a lower prevalence of hypnosedative users, yet a 
higher baseline prevalence of antipsychotic users than in 
our study. The lower prevalence of antipsychotic use in 
Belgium may have been the result of efforts made since 
the publication of the PHEBE study in Belgium (2006) 
[10]. The prevalence of antipsychotic use has decreased 
by more than 10%.
Discontinuation of antipsychotics can be hampered 
because of relapsing behavioural or psychological prob-
lems. There are often barriers, expressed by family as well 
as healthcare professionals (e.g. fear of returning aggressive 
behaviour by family members, fear of higher workload in 
patients with behavioural and psychological symptoms of 
dementia).
The absolute decrease of 9.1% in long-term psychotropic 
drug use can be considered a success. The decrease could 
have had a broader effect than measured in this study. For 
instance, for nursing personnel, it could have provided 
proof that non-pharmacological methods can be tailored to 
a patient and that they can be effective. For patients, the 
intervention could have led to clinically significant changes 
(e.g. improvements in alertness). From a health-economic 
perspective, a net saving in pharmacological costs can be 
expected.
4.2.4  Culture Within a Nursing Home as a Determinant
In our study, the intervention did not yield significant reduc-
tions for all classes in the separate nursing homes, poten-
tially owing to the differences in nursing home populations 
(varying level of care dependency and disorientation) and 
the number of nursing staff, or possibly because of differ-
ences in staff knowledge and motivation. It has been sug-
gested that a high prevalence of psychotropic drug use is 
not clearly associated with nursing home characteristics, but 
rather with the ‘culture’ within a nursing home [12, 30, 31]. 
A transition towards a culture where non-pharmacological 
alternatives are first considered is not easily implemented, 
considering existing limitations [32] and considering limited 
evidence [33, 34]. One of the perceived key points contribut-
ing to the success of this intervention was the inclusion of 
residents [35], their relatives and family [36], as well as all 
nursing home personnel, logistics staff, cleaning personnel 
and nursing home board of direction. Future research could 
focus on the contributing role of nursing home resident char-
acteristics and the characteristics of the nursing home (and 
employees) towards the success or failure of implementing 
similar initiatives.
4.2.5  Need for Further Broader Strategies
In a cohort of newly admitted nursing home residents in 
Flanders, Belgium, high antipsychotic use was noted. In 
these nursing home residents, signs of deprescribing for hyp-
nosedatives and antidepressants were noticed after 2 years 
in residents with poor physical and mental health, but not 
for antipsychotics [2]. The fact that nursing home residents 
often arrive in the nursing home with several psychotropic 
drugs already prescribed underlines the need for broader 
preventive strategies that are not solely embedded within 
the long-term care setting [17].
The high number of psychotropic drugs might be a 
consequence of inadequate strategies, either as a result of 
economic considerations or in-house attitudes towards psy-
chotropic medications [30]. In Belgium, for instance, the 
cost of psychotropic medications is covered either by the 
nursing home residents or health insurance, but offering non-
pharmacological alternatives is at the expense of the nursing 
home. More research may be needed to identify potential 
facilitators and barriers among nursing home personnel and 
residents when changing to person-centred care.
In this study, the hiring of an internal project leader (0.2 
FTE) was made possible by the funding received by the 
Flemish Government. In a later phase, project leaders need 
to be trained and assigned to nursing homes to guide the 
implementation. However, it must be reviewed if training 
and assigning extra personnel is cost effective, and if the 
intervention can lead to lowered healthcare usage (fewer 
falls, fewer GP visits, reduced medication costs).
5  Conclusions
An earlier practice improvement initiative was transcribed 
into a general intervention template. The intervention was 
implemented in five nursing homes in Flanders, Belgium. 
The combination of education, professional support and the 
transition towards patient-centred care proved successful in 
the discontinuation of high in-house psychotropic drug use. 
There was an overall significant reduction in total psycho-
tropic drug use, combined use of psychotropic drugs, and 
total hypnosedative and antidepressant use, but not in the 
use of antipsychotics.
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